| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Loranger Steven R is a Director at Edwards Lifesciences Corp with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $6.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | EW Edwards Lifesciences Corp | Director | Sale+OE | 5,739 | $76.42 | $438,575.53 | -8.7% | +0.9% | -0.4% | |
| Sep 11, 2020 | XYL Xylem Inc. | Director | Sell | 18,388 | $83.95 | $1,543,622.95 | -66.9% | - | - | |
| Feb 12, 2020 | XYL Xylem Inc. | Director | Sell | 30,000 | $88.61 | $2,658,378.00 | -29.3% | - | - | |
| Mar 15, 2019 | XYL Xylem Inc. | Director | Sell | 10,000 | $76.99 | $769,917.00 | -7.6% | - | - | |
| Dec 20, 2017 | XYL Xylem Inc. | Director | Sale+OE | 17,139 | $68.10 | $1,167,153.92 | -28.9% | - | - | |
| Dec 18, 2017 | XYL Xylem Inc. | Director | Sale+OE | 47,712 | $68.10 | $3,248,958.18 | -69.3% | - | - | |
| Dec 13, 2017 | XYL Xylem Inc. | Director | Sale+OE | 200 | $68.02 | $13,604.00 | -0.9% | - | - | |
| Dec 11, 2017 | XYL Xylem Inc. | Director | Sale+OE | 196 | $68.23 | $13,373.08 | -0.9% | - | - | |
| Nov 6, 2017 | XYL Xylem Inc. | Director | Sale+OE | 37,700 | $66.25 | $2,497,625.00 | -64.1% | - | - | |
| Jun 29, 2017 | XYL Xylem Inc. | Director | Sale+OE | 66,132 | $55.01 | $3,637,859.12 | -78.9% | - | - |